NHS Framework Agreement, Branded Medicines for London and South of England
Details
- Buyer
- NHS England
- Supplier(s)
41 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Allergan Limited
- Amgen Ltd
- Astra Zeneca UK Limited
- Bayer Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Celltrion Healthcare United Kingdom Ltd
- Chugai Pharma UK Ltd
- CST Pharma Limited
- Daiichi Sankyo UK Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- Ipsen
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Merz
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Profile Pharma Ltd
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- TECHDOW PHARMA ENGLAND LIMITED
- Tetris Pharma Lts
- Teva UK Ltd
- Thornton and Ross
- UCB
- UL Global Pharma
- Vifor Pharma UK Ltd
- Zentiva Pharma UK Ltd
- Value
- GBP 558,521,926
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 17 September 2021
- Source
- uk:contracts_finder
Tender description
NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months
Timeline
- Completed: Award date19 August 2021
- Completed: Award published17 September 2021Current notice
- Completed: Contract expiry date31 August 2023
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework Agreement, Branded Medicines for London and South of England.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 366£249.3m
- 352£15.0bn
- 292£2.8bn
- 260£19.7bn
- 252£892.4m
- 241£508.7m
- 203£1.0bn
- 139£895.4m
- 114£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
